Overview

Gender

male

Investor Type

Investment Partner

Dr. Gregory Grunberg joined Longitude Capital in 2012 as a Managing Director. He focuses on investments in medical devices and biotechnology.

Prior to joining Longitude, Dr. Grunberg was a Principal at Rho Ventures, a multi-stage, multi-sector fund, where he participated in medical device, biotechnology and other healthcare investments. Before joining Rho, Dr. Grunberg was an Engagement Manager in the life sciences practice of McKinsey & Company. While at McKinsey, he worked with many large life sciences companies and private equity investors across a range of projects encompassing investment due diligence, business development, R&D, and product development. He also consulted at The Parthenon Group and led his own health care advisory firm during graduate school. Greg is a board-certified physician in Internal Medicine and completed his residency at Weill-Cornell’s New York Presbyterian Hospital. He has maintained a limited clinical practice in Internal Medicine and affiliations with UCSF, Kaiser, Albert Einstein, U. Miami, Weill-Cornell, and the Weill-Cornell Buganda Medical School in Tanzania.